The mechanism leading to reduced expression of Foxp3 and CTLA-4 and consequently, deficient suppressive activity of CD4+CD25+ T cells from patients with cardiomyopathy has not been elucidated. This evidence concerns the gene FOXP3 and cardiomyopathy.